tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Strong Q3 Performance and Promising Growth Prospects Drive Buy Rating for Vericel
PremiumRatingsStrong Q3 Performance and Promising Growth Prospects Drive Buy Rating for Vericel
2M ago
Vericel reports Q3 EPS 10c, consensus (1c)
Premium
The Fly
Vericel reports Q3 EPS 10c, consensus (1c)
2M ago
Vericel sees FY25 revenue $272M-$276M, consensus $275.21M
Premium
The Fly
Vericel sees FY25 revenue $272M-$276M, consensus $275.21M
2M ago
Vericel downgraded to Neutral from Buy at BTIG
PremiumThe FlyVericel downgraded to Neutral from Buy at BTIG
4M ago
Vericel’s Phase 3 Study on MACI: A Potential Game-Changer in Cartilage Repair
Premium
Company Announcements
Vericel’s Phase 3 Study on MACI: A Potential Game-Changer in Cartilage Repair
4M ago
Vericel’s MACI Arthro: Driving Over 20% Growth with Market Expansion and Innovation
Premium
Ratings
Vericel’s MACI Arthro: Driving Over 20% Growth with Market Expansion and Innovation
5M ago
Vericel Corporation Reports Strong Q2 2025 Results
PremiumCompany AnnouncementsVericel Corporation Reports Strong Q2 2025 Results
5M ago
Vericel’s Strong Growth and Operational Efficiency Justify Buy Rating Despite Slight Performance Miss
Premium
Ratings
Vericel’s Strong Growth and Operational Efficiency Justify Buy Rating Despite Slight Performance Miss
5M ago
Vericel reports Q2 EPS (1c), consensus (4c)
Premium
The Fly
Vericel reports Q2 EPS (1c), consensus (4c)
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100